Previous close | 7,488.30 |
Open | 0.00 |
Bid | 0.00 x 100 |
Ask | 7,765.79 x 100 |
Day's range | 7,488.30 - 7,488.30 |
52-week range | 5,665.00 - 7,607.96 |
Volume | |
Avg. volume | 133 |
Market cap | 2T |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 28.57 |
EPS (TTM) | 262.09 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 29, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.